J0879 Insurance Policy Changes

HCPCS J0879 is officially defined as "Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)." HCPCS J0879 is referenced in 3 tracked payer policy changes from Blue Cross & Blue Shield of Mississippi and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0879 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.